Phase I Trials of New Antitumor Platinum Complexes

Creaven, Patrick J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA062509-03
• Application #: 2103806
• Study Section: Special Emphasis Panel (SRC (74))
• Project Start: 1994-03-04
• Project End: 1998-01-31
• Budget Start: 1996-02-01
• Budget End: 1997-01-31
• Support Year: 3
• Fiscal Year: 1996

Institution

• Name: Roswell Park Cancer Institute Corp
• City: Buffalo
• State: NY
• Country: United States
• Zip Code: 14263

Publications

Smith, Patrick F; Booker, Brent M; Creaven, Patrick et al. (2003) Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion. J Clin Pharmacol 43:1324-8

Pendyala, L; Creaven, P J; Schwartz, G et al. (2000) Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione. Clin Cancer Res 6:1314-21